Cite
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer
MLA
Naohide Oue, et al. “Overexpression of Claspin Promotes Docetaxel Resistance and Is Associated with Prostate-Specific Antigen Recurrence in Prostate Cancer.” Cancer Medicine, vol. 10, no. 16, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a8eb586b5b10b2a7075370cbe2397247&authtype=sso&custid=ns315887.
APA
Naohide Oue, Go Kobayashi, Shintaro Akabane, Akio Matsubara, Masaki Shiota, Wataru Yasui, Jun Teishima, Tetsutaro Hayashi, Daiki Taniyama, Takashi Babasaki, Kazuhiro Sentani, Yohei Sekino, Quoc Thang Pham, & Narutaka Katsuya. (2021). Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer. Cancer Medicine, 10(16).
Chicago
Naohide Oue, Go Kobayashi, Shintaro Akabane, Akio Matsubara, Masaki Shiota, Wataru Yasui, Jun Teishima, et al. 2021. “Overexpression of Claspin Promotes Docetaxel Resistance and Is Associated with Prostate-Specific Antigen Recurrence in Prostate Cancer.” Cancer Medicine 10 (16). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a8eb586b5b10b2a7075370cbe2397247&authtype=sso&custid=ns315887.